Clinical

Insightec low-intensity focused ultrasound opens blood-brain barrier in Alzheimer’s patients

December 13, 2019

There is no FDA-approved medication for Alzheimer’s disease. But there is some hope that if the blood-brain barrier could be more easily penetrated by drug candidates they would prove more effective. That is the line of research being pursued by Israeli company Insightec Ltd. via its Exablate Neuro that provides low-intensity focused ultrasound treatment.

Israeli, U.S. teams collaborate on technology for respiratory tract diseases

December 6, 2019

By Jihyun Kim

No Comments

HONG KONG – Negev-based Ben-Gurion University (BGU) and Beersheba-based Soroka Medical Center in Israel, working with the Cincinnati Children's Hospital Medical Center and the University of Cincinnati (UC), have developed a technology for unblocking and removing secretions from airways to to treat patients with diseases affecting the respiratory tract.

Boston Sci’s Watchman scores well at 50 months for hemorrhagic stroke

December 5, 2019

By Mark McCarty

No Comments

The Watchman left atrial appendage device, distributed by Marlborough, Mass.-based Boston Scientific Corp., holds a unique place in the annals of med tech regulation, but 50-month data from two registries show a lower rate of hemorrhagic stroke than previously reported for the device.

Study bolsters case for stenting over bypass in long femoropopliteal lesions

November 27, 2019

By Mark McCarty

No Comments

The recent controversy over the use of paclitaxel in the peripheral vasculature has clouded the larger debate over whether bypass is superior to endovascular therapies for the lower limbs. However, a new study suggests that nitinol stents provide a feasible alternative to bypass even for lesions of the femoropopliteal artery that are 30 cm in length.

High adherence seen with Digimeds in difficult to treat HCV patients

November 27, 2019

By Annette Boyle

No Comments

Proteus Digital Health Inc.’s digital medicine program, Digimeds, achieved 95% adherence in patients with hepatitis C virus (HCV) who typically would not be offered direct acting antivirals because of their high risk for nonadherence as a result of mental illness, transportation issues or previous evidence of nonadherence.

Mologic begins recruitment of COPD urine-based home test

November 25, 2019

By Nuala Moran

No Comments

LONDON – Mologic Ltd. has started recruitment in a 263-patient trial to validate its urine-based home test for anticipating exacerbations of chronic pulmonary obstructive disease (COPD). The lateral flow immunoassay self-test detects five biomarkers of the lung disease in urine that are indicative of inflammation and infection.

Study supports long-term performance of Senseonics’ Eversense CGM

November 22, 2019

By Meg Bryant

No Comments

Germantown, Md.-based Senseonics Inc. said results from a recent study confirm that the sensor in its Eversense continuous glucose monitoring (CGM) system performs well over multiple, sequential 90-day and 180-day cycles. The real-world trial assessed the accuracy of the Eversense data management system by comparing sensor blood sugar values with self-monitored glucose values in 945 adults.

Apple Heart Study delivers results as 3 new app-based trials begin

November 22, 2019

By Stacy Lawrence

No Comments

Stanford University School of Medicine and Apple Inc.have published results from the largest digital-only study. The trial has been conducted in more than 400,000 people in the U.S. over more than eight months. It was set up to screen participants via their Apple Watch for heart irregularities and then to further monitor any of those with identified issues with a wearable ECG patch.

Intestinal resurfacing startup Fractyl plans 2020 pivotal trial as it reports positive data

November 19, 2019

By Stacy Lawrence

No Comments

Fractyl Laboratories Inc. is pioneering a procedure known as duodenal mucosal resurfacing (DMR) to reverse chronic metabolic disorders. This month it has reported positive results from a couple of clinical trials that are shaping its planning for a pivotal trial that is slated to start next year in type 2 diabetes patients.

Sapien bests Corevalve Evolut in twin French TAVR studies

November 18, 2019

By Mark McCarty

No Comments

Edwards Lifesciences and Medtronic have struggled for supremacy for transcatheter aortic valve devices for several years, but two recent studies suggest the Edwards line of devices provide better outcomes. However, another study gave new life to the notion that TAVR devices are underutilized, signaling that there is plenty of market for both companies.

Clinical, BioWorld MedTech
RSS

Insightec low-intensity focused ultrasound opens blood-brain barrier in Alzheimer’s patients

Israeli, U.S. teams collaborate on technology for respiratory tract diseases

Boston Sci’s Watchman scores well at 50 months for hemorrhagic stroke

Study bolsters case for stenting over bypass in long femoropopliteal lesions

High adherence seen with Digimeds in difficult to treat HCV patients

Mologic begins recruitment of COPD urine-based home test

Study supports long-term performance of Senseonics’ Eversense CGM

Apple Heart Study delivers results as 3 new app-based trials begin

Intestinal resurfacing startup Fractyl plans 2020 pivotal trial as it reports positive data

Sapien bests Corevalve Evolut in twin French TAVR studies

Popular Stories

Bioworld MedTech’s Oncology Extra

FDA gives thumbs up to Cochlear’s implantable bone conduction hearing system

Analysis by U.K. startup Medbelle highlights extent of drug pricing disparity

Buoyed by optimism and love of family, former FDA chief Frank Young leaned into storms

Biopharma companies continue their strong momentum in November

BioWorld Premium

Clinical, BioWorld MedTech RSS

Popular Stories

BioWorld Premium

Clinical, BioWorld MedTech
RSS